Selecta Biosciences: Funding, Investors & Team (Oct 2026)
Selecta Biosciences Inc. (NASDAQ: SELB) and Cartesian Therapeutics have merged in November 2023 to form a publicly traded company that specializes in RNA cell therapy for autoimmune disease treatment. This newly formed company will primarily prioritize the advancement of Cartesian's Descartes-08, a clinical-stage lead product candidate used to assess patients with myasthenia gravis and various other autoimmune conditions. If you would like more information or updates regarding the company, please visit https://www.cartesiantherapeutics.com/ or follow our LinkedIn page @Cartesian-Therapeutics.
Selecta Biosciences has raised $60.3M across 1 funding round on record, the most recent an undisclosed round of $60.3M announced in Nov 2023.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Selecta Biosciences Company Profile and Key Stats
Latest funding round on record: Nov 2023.
Selecta Biosciences Funding Rounds
Selecta Biosciences Founders and Leadership Team
No contact details are on record for this team yet.
Selecta Biosciences Funding Compared to Other Biotechnology Startups
Selecta Biosciences' latest round of $60.3M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Selecta Biosciences in Biotechnology and Watertown
Companies Similar to Selecta Biosciences
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Selecta Biosciences Funding FAQs
What does Selecta Biosciences do?
Selecta Biosciences Inc. (NASDAQ: SELB) and Cartesian Therapeutics have merged in November 2023 to form a publicly traded company that specializes in RNA cell therapy for autoimmune disease treatment. This newly formed company will primarily prioritize the advancement of Cartesian's Descartes-08, a clinical-stage lead product candidate used to assess patients with myasthenia gravis and various other autoimmune conditions. If you would like more information or updates regarding the company, please visit https://www.cartesiantherapeutics.com/ or follow our LinkedIn page @Cartesian-Therapeutics.
How much funding has Selecta Biosciences raised?
Selecta Biosciences has raised $60.3M across 1 round on record. The most recent is an undisclosed round of $60.3M announced in Nov 2023.
When did Selecta Biosciences last raise funding?
Selecta Biosciences' most recent funding round on record is an undisclosed round of $60.3M, announced in Nov 2023.
Who founded Selecta Biosciences?
FundedIQ lists Peter Traber (Founder) at Selecta Biosciences.
Where is Selecta Biosciences headquartered?
Selecta Biosciences is based in Watertown, Massachusetts, United States.
How many employees does Selecta Biosciences have?
Selecta Biosciences is in the 51-100 employee band.
How does Selecta Biosciences' funding compare to other Biotechnology startups?
Selecta Biosciences' latest round of $60.3M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Selecta Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Selecta Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.